https://aapsonline.org/fda-bureaucrat-brags-he-blocked-physician-prescribing-of-hydroxychloroquine-in-early-covid-19 Dr. Lee Charles Moscowitz Interview with Dr. Vliet on COVID-19 and HCQ
https://youtu.be/rGlI78p8MEE India has been successfully using hydroxychloroquine for both prevention/prophylaxis AND treatment of COVID-19 since early in this outbreak.
India’s model is to use hydroxychloroquine
1) once a week dosing for prophylaxis for doctors, nurses, other healthcare workers, as well as exposed, high risk individuals, AND
2) early treatment intervention with a daily dosing regimen when patients become symptomatic.
As a result of early and widespread use of hydroxychloroquine, India’s overall number of cases and deaths per million population are far lower than the United States, where hydroxychloroquine use has been restricted by governors and the FDA to be used late stage COVID-19 disease in hospitalized patients. See the comparison data chart in the Editorial: Doctors and Patients are Pawns in a Game of Political Brinkmanship also available here on this page of our website.
India-ICMR Advisory on HCQ Use.pdf Download Dr. Vliet presents the side-by-side research-based comparison of two medicines in the news for treating COVID-19, or coronavirus, also known by its medical name SARS-CoV2: hydroxychloroquine, the older generic anti-malarial/antiviral FDA-approved since 1955, and the new experimental antiviral, remdesivir, developed by Gilead Sciences in partnership with the NIH, CDC and US Army initially for use in Ebola. Dr. Vliet has reviewed the worldwide data, clinical outcomes, side effects, death rates, costs, and other aspects of both medicines and explains important differences for readers to discuss with their own physicians in the event of a COVID illness.
Dr. Vliet has reviewed the interview from these two California physicians and recommends it to our readers and patients. They bring an important, and medically sound, perspective to the discussion about the potential risks of prolonged “stay at home” orders, and explain the importance of developing “herd immunity” much in a more reasonable approach to our activities, which is also the model that has worked well in Sweden.
“West coast physicians warn: Stay-at-home orders could actually harm our health by weakening immunity. In an April 22 interview with a local Californian news station, Dr. Erickson and Dr. Massihi of Accelerated Urgent Care in Bakersfield, CA state that based on their data – which includes over 5,200 patients tested for COVID-19, or more than half of all the testing in their county), the chances of dying of COVID-19 in their community is less than one percent (about 0.03 percent, according to Dr. Erickson).As a comparison, the seasonal flu has a reported fatality rate of 0.1 percent. Meanwhile, the tentative fatality rate for COVID-19 overall seems to hover somewhere around 3 to 6 percent – yet a Columbia University study suggests that due to underreporting of total cases, the actual fatality rate could be closer to 0.6 percent.
Clearly, it’s difficult to know what the true fatality rate of COVID-19 is right now, simply because this is an actively ongoing pandemic. Plus, different communities are affected in different ways (due to factors like population age, comorbid conditions, etc). Still, Dr. Erickson and Dr. Massih deeply question the strict “shelter-in-place” orders for Californians, and strongly suspect that the virus simply isn’t as deadly as some officials would have us believe (and therefore not a justifiable reason to literally shut down the economy). They further contend that California’s extreme, no-end-in-sight COVID-19 policy could cause more harm than good.
Dr. Vliet on with Dan Rea, WBZ Nightside in Boson April 30, 2020, discussing Remdesivir and Hydroxychloroquine treatments in COVID-19
Governors are blocking doctors’ attempts to save lives
Exclusive: Elizabeth Lee Vliet, M.D., asks why pols are ‘making arbitrary medical edicts’
Doctors and Patients Are Pawns in a Dangerous Political Brinkmanship
By Elizabeth Lee Vliet, M.D., Preventive Medicine April 27th, 2020